To date there is no cure available for dementia, and the field calls for novel therapeutic targets. A rapidly growing body of literature suggests that regular endurance training and high cardiorespiratory fitness attenuate ...

Alzheimer’s disease (AD) is the most common cause of dementia and there is currently no cure. Novel approaches to treat AD and curb the rapidly increasing worldwide prevalence and costs of dementia are needed. Physical ...

Alzheimer’s disease (AD) is a progressive, neurodegenerative disease where accumulation of neuropathology can start up to two decades before symptom onset. With no cure for the disease, relevant models of AD are needed to ...

Alzheimers sykdom er en progressiv, og dødelig nevrodegenerativ sykdom, karakterisert av de nevropatpologiske kjennetegne amyloid-β plakk og nevrofibrillære floker. Det har blitt estimert at de patologiske celleforandringene ...

Alzheimer’s disease is a slowly progressing and ultimately fatal neurodegenerative disease affecting more than 46 million people worldwide in 2018. The entorhinal cortex (EC), in particular the layer II of the domains ...

Abstract will be available on 2027-12-31

The identification of neuronal markers, that is, molecules selectively present in subsets of neurons, contributes to our understanding of brain areas and the networks within them. Specifically, recognizing the distribution ...

The entorhinal-hippocampal system contains distinct networks subserving declarative memory. This system is selectively vulnerable to changes of ageing and pathological processes. The entorhinal cortex (EC) is a pivotal ...

Background The Personal Activity Intelligence (PAI) translates heart rate during daily activity into a weekly score. Obtaining a weekly PAI score ≥100 is associated with reduced risk of premature morbidity and mortality ...